Exchange Traded Concepts, LLC Axogen, Inc. Transaction History

Exchange Traded Concepts, LLC

$10.4 Billion
Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 58,640 shares of AXGN stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

58,640

Previous 77,312 24.15%

Holding current value

$1.01 Million

Previous $838,000 24.82%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$10.77 - $17.84 $201,097 - $333,108	-18,672 Reduced 24.15%	58,640 $1.05 Million
Q2 2025 Jul 10, 2025	BUY	$9.29 - $17.81 $242,255 - $464,431	26,077 Added 50.9%	77,312 $838,000
Q1 2025 Apr 17, 2025	SELL	$14.56 - $20.11 $190,488 - $263,099	-13,083 Reduced 20.34%	51,235 $947,000
Q4 2024 Jan 21, 2025	SELL	$12.47 - $17.19 $129,987 - $179,188	-10,424 Reduced 13.95%	64,318 $1.06 Million
Q3 2024 Oct 10, 2024	SELL	$7.52 - $14.69 $546,824 - $1.07 Million	-72,716 Reduced 49.31%	74,742 $1.05 Million
Q2 2024 Aug 13, 2024	BUY	$5.67 - $8.06 $231,415 - $328,960	40,814 Added 38.27%	147,458 $1.07 Million
Q1 2024 Apr 15, 2024	BUY	$6.63 - $10.69 $177,558 - $286,288	26,781 Added 33.53%	106,644 $860,000
Q4 2023 Jan 05, 2024	SELL	$3.61 - $7.76 $100,368 - $215,751	-27,803 Reduced 25.82%	79,863 $545,000
Q3 2023 Oct 18, 2023	BUY	$4.68 - $9.26 $81,815 - $161,883	17,482 Added 19.38%	107,666 $538,000
Q2 2023 Jul 20, 2023	SELL	$8.5 - $10.38 $66,682 - $81,431	-7,845 Reduced 8.0%	90,184 $823,000
Q1 2023 Apr 12, 2023	BUY	$7.53 - $10.95 $151,834 - $220,795	20,164 Added 25.9%	98,029 $926,000
Q4 2022 Jan 17, 2023	SELL	$9.44 - $13.09 $120,718 - $167,394	-12,788 Reduced 14.11%	77,865 $777,000
Q3 2022 Oct 07, 2022	SELL	$8.14 - $12.25 $28,970 - $43,597	-3,559 Reduced 3.78%	90,653 $1.08 Million
Q2 2022 Jul 20, 2022	SELL	$6.99 - $10.0 $1.06 Million - $1.51 Million	-151,117 Reduced 61.6%	94,212 $772,000
Q1 2022 Apr 26, 2022	SELL	$7.26 - $10.7 $391,379 - $576,826	-53,909 Reduced 18.02%	245,329 $1.95 Million
Q4 2021 Jan 13, 2022	BUY	$8.8 - $16.0 $814,378 - $1.48 Million	92,543 Added 44.77%	299,238 $2.8 Million
Q3 2021 Oct 18, 2021	BUY	$15.23 - $21.72 $556,900 - $794,213	36,566 Added 21.49%	206,695 $3.27 Million
Q2 2021 Jul 30, 2021	BUY	$17.8 - $23.5 $438,948 - $579,510	24,660 Added 16.95%	170,129 $3.68 Million
Q1 2021 Apr 20, 2021	BUY	$17.18 - $22.6 $697,508 - $917,560	40,600 Added 38.71%	145,469 $2.95 Million
Q4 2020 Jan 19, 2021	BUY	$11.5 - $17.96 $548,354 - $856,386	47,683 Added 83.38%	104,869 $1.88 Million
Q3 2020 Oct 30, 2020	BUY	$10.62 - $13.12 $238,195 - $294,268	22,429 Added 64.53%	57,186 $665,000
Q2 2020 Jul 15, 2020	BUY	$7.35 - $10.81 $156,606 - $230,328	21,307 Added 158.42%	34,757 $321,000
Q1 2020 Apr 14, 2020	BUY	$8.38 - $17.34 $64,844 - $134,176	7,738 Added 135.47%	13,450 $140,000
Q4 2019 Jan 22, 2020	BUY	$11.18 - $18.6 $63,860 - $106,243	5,712 New	5,712 $102,000

Others Institutions Holding AXGN

# of Institutions

172

Shares Held

40.5M

Call Options Held

69.1K

Put Options Held

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $729M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Axogen, Inc. Transaction History